FundFollowerFundFollower
Super FundsTop AssetsActivityPortfoliosArticlesAbout

Get the FundFollower newsletter

13F-season insights and notable moves. No spam — unsubscribe anytime.

© 2025 FundFollower. All rights reserved.

Data sourced from public SEC filings.

HomeContact UsSuper FundsTop AssetsAbout

Lineage Cell Therapeutics Inc.

LCTX

2 institutional investors and hedge funds own LCTX, holding 4,741,191 shares worth $205.1M (latest 13F filings).

Advanced Chart

Who owns Lineage Cell Therapeutics Inc. stock?

Institutional holders of LCTX — largest position first.

Super Fund
Position
Shares
Curr. Value
Port. %
Activity
D1 Capital PartnersEquity
4,736,312
$204,845,494
0.59%
-36.02%
Brookfield CorporationEquity
4,879
$211,017
0.00%
-95.93%

Ownership Statistics

Total Shares Held: 4,741,191
Total Value Reported: $205,056,511
Average Allocation per Portfolio 0.29%
Largest Single Portfolio Allocation: 0.59%
Largest Shareholder: D1 Capital Partners
Change in Total Shares Held (Q on Q): -2,780,950
Percentage Change in Shares Held (Q on Q): -36.97%
Number of Super Fund Holders: 2
Number of New Holders (Q on Q): 0
Number of Funds with Additions (Q on Q): 0
Number of Funds with Reductions (Q on Q): 2
Number of Funds Fully Divested (Q on Q): 0
Number of Funds with No Change (Q on Q): 0

Ownership Distribution

Loading chart…

Ownership History

Loading chart…

Company Profile

Fundamental Data